Cargando…

Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration

Sorafenib, a multiple-target tyrosine kinase inhibitor, is the standard of care for patients with advanced hepatocellular carcinoma (HCC), but provides limited benefits. Emerging evidences suggest that prolonged sorafenib treatment induces an immunosuppressive HCC microenvironment, but the underling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Lijuan, Wang, Nanya, Wang, Qiang, Fan, Xia, Xin, Yuning, Wang, Shudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008628/ https://www.ncbi.nlm.nih.gov/pubmed/36906597 http://dx.doi.org/10.1038/s41420-023-01392-3

Ejemplares similares

The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
por: Yang, Fan, et al.
Publicado: (2018)

Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022)

Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China
por: Qin, Shukui, et al.
Publicado: (2018)

Improving cancer immunotherapy by targeting the STATe of MDSCs
por: de Haas, Nienke, et al.
Publicado: (2016)

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
por: Okła, Karolina, et al.
Publicado: (2019)

PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response Activity
por: Guo, Shuang, et al.
Publicado: (2022)

Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
por: Xue, Yaxian, et al.
Publicado: (2019)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma
por: Shaheen, Karim Y. A., et al.
Publicado: (2015)

Tertiary sulphonamide derivatives as dual acting small molecules that inhibit LSD1 and suppress tubulin polymerisation against liver cancer
por: Ding, Lijuan, et al.
Publicado: (2021)

Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs‐Targeting Immunotherapy of Colon Cancer
por: Ding, Dongbing, et al.
Publicado: (2021)

Midkine in Inflammation
por: Weckbach, Ludwig T., et al.
Publicado: (2011)

Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation
por: Ray, Anuradha, et al.
Publicado: (2013)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

Correction to: Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
por: Xue, Yaxian, et al.
Publicado: (2022)

Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma
por: Hodeib, Hossam, et al.
Publicado: (2017)

Diagnostic accuracy of midkine on hepatocellular carcinoma: A meta-analysis
por: Zhang, Bo-han, et al.
Publicado: (2019)

Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta‐analysis
por: Zhang, Yu, et al.
Publicado: (2019)

Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity
por: Forghani, Parvin, et al.
Publicado: (2017)

Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression
por: Gao, Yingying, et al.
Publicado: (2020)

Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response
por: Jiang, Hongye, et al.
Publicado: (2021)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy
por: He, Wei, et al.
Publicado: (2016)

Role of Rip2 in Development of Tumor-Infiltrating MDSCs and Bladder Cancer Metastasis
por: Zhang, Hanwei, et al.
Publicado: (2014)

Midkine, a Potential Link between Obesity and Insulin Resistance
por: Fan, Nengguang, et al.
Publicado: (2014)

Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
por: Ko, Yi-Ling, et al.
Publicado: (2020)

The downregulation of type I IFN signaling in G-MDSCs under tumor conditions promotes their development towards an immunosuppressive phenotype
por: Sun, Yingying, et al.
Publicado: (2022)

Involvement of midkine in the development of pulmonary fibrosis
por: Misa, Kenichi, et al.
Publicado: (2017)

New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs
por: Lakshmanachetty, Senthilnath, et al.
Publicado: (2021)

MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
por: Wang, Yungang, et al.
Publicado: (2019)

Dose-Dependent Sorafenib-Induced Immunosuppression Is Associated with Aberrant NFAT Activation and Expression of PD-1 in T Cells
por: Iyer, Renuka V., et al.
Publicado: (2019)

Midkine’s Role in Cardiac Pathology
por: Woulfe, Kathleen C., et al.
Publicado: (2017)

A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment
por: Kuo, Cheng-Liang, et al.
Publicado: (2022)

Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma
por: Vongsuvanh, Roslyn, et al.
Publicado: (2016)

Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy
por: Zheng, Jian-feng, et al.
Publicado: (2015)

Sorafenib in the treatment of patients with hepatocellular carcinoma (HCC) and microvascular infiltration: a systematic review and meta-analysis
por: Gu, Wang, et al.
Publicado: (2020)

Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer
por: Toyoda, Eiji, et al.
Publicado: (2008)

IM-1 THE IMMUNOSUPPRESSIVE ROLE OF MAIT CELLS AND MR1 IN GBM THROUGH THE INDUCTION OF NEUTROPHILS AND MDSCS
por: Hana, Taijun, et al.
Publicado: (2022)

ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer
por: Chen, Huanhuan, et al.
Publicado: (2023)

Sorafenib Combined with Cryoablation to Treat Unresectable Hepatocellular Carcinoma
por: Ni, Hong, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mi5asikrfia58n7i67br4fklph